EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

APOA2 increases cholesterol efflux capacity to plasma HDL by displacing the C-terminus of resident APOA1

Snigdha Sarkar, Jamie Morris, Youngki You, Hannah Sexmith, Scott E Street, Stephanie M Thibert, Isaac K Attah, Chelsea M Hutchinson Bunch, Irina V Novikova, James E Evans, Amy S Shah, Scott M Gordon und 6 weitere

Journal of Lipid Research · 2024

DOI: 10.1016/j.jlr.2024.100686 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Lipid Research, 2024. Verfasst von Snigdha Sarkar und 17 weiteren Autor:innen. Beteiligte Einrichtung: Biological Sciences Division, Pacific Northwest National Laboratory, Richland, WA, USA. Hauptthemen laut MEDLINE: Apolipoprotein A-I, Lipoproteins, HDL, Cholesterol, Apolipoprotein A-II. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, NINDS NIH HHS, NIA NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The ability of high-density lipoprotein (HDL) to promote cellular cholesterol efflux is a more robust predictor of cardiovascular disease protection than HDL-cholesterol levels in plasma. Previously, we found that lipidated HDL containing both apolipoprotein A-I (APOA1) and A-II (APOA2) promotes cholesterol efflux via the ATP-binding cassette transporter (ABCA1). In the current study, we directly added purified, lipid-free APOA2 to human plasma and found a dose-dependent increase in whole plasma cholesterol efflux capacity. APOA2 likewise increased the cholesterol efflux capacity of isolated HDL with the maximum effect occurring when equal masses of APOA1 and APOA2 coexisted on the particles. Follow-up experiments with reconstituted HDL corroborated that the presence of both APOA1 and APOA2 were necessary for the increased efflux. Using limited proteolysis and chemical cross-linking mass spectrometry, we found that APOA2 induced a conformational change in the N- and C-terminal helices of APOA1. Using reconstituted HDL with APOA1 deletion mutants, we further showed that APOA2 lost its ability to stimulate ABCA1 efflux to HDL if the C-terminal domain of APOA1 was absent, but retained this ability when the N-terminal domain was absent. Based on these findings, we propose a model in which APOA2 displaces the C-terminal helix of APOA1 from the HDL surface which can then interact with ABCA1-much like it does in lipid-poor APOA1. These findings suggest APOA2 may be a novel therapeutic target given this ability to open a large, high-capacity pool of HDL particles to enhance ABCA1-mediated cholesterol efflux.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Apolipoprotein A-ILipoproteins, HDLCholesterolApolipoprotein A-IIHumansATP Binding Cassette Transporter 1Biological Transport

Stichwörter der Autor:innen

ABCA1Apolipoprotein A-IApolipoprotein A-IIApolipoprotein(s)Cholesterol EffluxHigh Density LipoproteinsLipoprotein metabolismLipoproteinsStructure

Substanzen

Apolipoprotein A-ILipoproteins, HDLCholesterolApolipoprotein A-IIATP Binding Cassette Transporter 1ABCA1 protein, humanAPOA1 protein, human

Autor:innen und Institutionen

  • Biological Sciences Division, Pacific Northwest National Laboratory, Richland, WA, USA.
  • Department of Pathology and Laboratory Medicine, University of Cincinnati, Cincinnati, OH, USA.
  • Department of Pediatrics, Cincinnati Children's Hospital Medical Center and the University of Cincinnati, Cincinnati, OH, USA.
  • Environmental Molecular Sciences Laboratory, Pacific Northwest National Laboratory, Richland, WA, USA.
  • Department of Physiology and the Saha Cardiovascular Research Center, University of Kentucky College of Medicine, Lexington, KY, USA.
  • Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.

Förderung

  • NHLBI NIH HHS
  • NINDS NIH HHS
  • NIA NIH HHS
  • NIDDK NIH HHS
  • National Institute on Aging
  • National Heart Lung and Blood Institute Division of Intramural Research

Zitieren

APA

Sarkar, S., Morris, J., You, Y., Sexmith, H., Street, S. E., Thibert, S. M., Attah, I. K., Hutchinson Bunch, C. M., Novikova, I. V., Evans, J. E., Shah, A. S., Gordon, S. M., Segrest, J. P., Bornfeldt, K. E., Vaisar, T., Heinecke, J. W., Davidson, W. S., & Melchior, J. T. (2024). APOA2 increases cholesterol efflux capacity to plasma HDL by displacing the C-terminus of resident APOA1. Journal of Lipid Research. https://doi.org/10.1016/j.jlr.2024.100686

Vancouver

Sarkar S, Morris J, You Y, Sexmith H, Street SE, Thibert SM, et al. APOA2 increases cholesterol efflux capacity to plasma HDL by displacing the C-terminus of resident APOA1. Journal of Lipid Research. 2024. doi:10.1016/j.jlr.2024.100686

BibTeX
@article{Sarkar2024,
  author = {Sarkar, Snigdha and Morris, Jamie and You, Youngki and Sexmith, Hannah and Street, Scott E and Thibert, Stephanie M and Attah, Isaac K and Hutchinson Bunch, Chelsea M and Novikova, Irina V and Evans, James E and Shah, Amy S and Gordon, Scott M and Segrest, Jere P and Bornfeldt, Karin E and Vaisar, Tomas and Heinecke, Jay W and Davidson, W Sean and Melchior, John T},
  title = {APOA2 increases cholesterol efflux capacity to plasma HDL by displacing the C-terminus of resident APOA1},
  journal = {Journal of Lipid Research},
  year = {2024},
  doi = {10.1016/j.jlr.2024.100686}
}
Kostenlos starten →